Tuesday, February 5, 2013

Investopedia: Mead Johnson Nutrition's Valuation Looks Bloated

Investors are almost always willing to pay up for growth, particularly when it's in a sector where growth can otherwise be hard to come by. But Mead Johnson Nutrition (NYSE:MJN) shares seem to take that a little too far. There's no arguing that the company's heavy exposure to faster-growing emerging markets is a big plus, not to mention its strong share in what is effectively becoming a global oligopoly. Even so, investors shouldn't ignore the risk of further margin pressure and the possibility that they're paying too much for these shares.

To read more, please follow this link:
http://www.investopedia.com/stock-analysis/2013/Mead-Johnson-Nutritions-Valuation-Looks-Bloated-MJN-ABT-NSRGY-DF0205.aspx

No comments: